Search results

activity in PTC with oral angiogenesis/multikinase inhibitors , such as AMG 706 (Sherman, NEJM, 2008) and sorafenib ... in other targeted therapies, such as mTOR inhibitors or c-metinhibitors , however there is no published clinical data to date on ...